FDA perspective on trials with interim efficacy evaluations. Temple R. Stat Med. 2006 Oct 15;25(19):3245-9; discussion 3326-47. doi: 10.1002/sim.2631. PMID: 16847824
Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop. Nair P, Aiello LP, Gardner TW, Jampol LM, Ferris FL. Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5127-5142. doi: 10.1167/iovs.16-20356. PMID: 27699406
Food and Drug Administration audit of foreign clinical trials. Sloboda W, Lisook AB. Psychopharmacol Bull. 1987;23(1):193-5. PMID: 3602320
[Observational studies to evaluate the clinical effectiveness of drugs. Use of guide lists for their design, analysis, and interpretation]. Soto Alvarez J. Aten Primaria. 2005 Feb 28;35(3):156-62. doi: 10.1157/13071942. PMID: 15737273
Clinical drug tests adapted for speed. Ledford H. Nature. 2010 Apr 29;464(7293):1258. doi: 10.1038/4641258a. PMID: 20428134
On reducing waste in foreign clinical trials and postregulation experience. Lasagna L. Clin Pharmacol Ther. 1986 Oct;40(4):369-72. doi: 10.1038/clpt.1986.192. PMID: 3757400
